0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Immuno Oncology Assays Market: Insights and Competitive AnalysisExecutive Summary Immuno Oncology Assays Market Size and Share Across Top Segments CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period To better structure this Immuno Oncology Assays report, a nice blend of...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Late-Stage Oncology Drug Pipeline Market Share and Size Report: Emerging Trends and Forecast Analysis" According to the latest report published by Data Bridge Market Research, the Late-Stage Oncology Drug Pipeline Market The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period A large scale Late-Stage Oncology Drug...0 Комментарии 0 Поделились 184 Просмотры 0 предпросмотр
-
Long-Acting Injectable Oncology Drug Market Size Forecast and Segment AnalysisAccording to the latest report published by Data Bridge Market Research, the Long-Acting Injectable Oncology Drug Market The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period Quality and transparency has been strictly maintained while carrying...0 Комментарии 0 Поделились 96 Просмотры 0 предпросмотр
-
Oral Targeted Oncology Drug Market Report: Growth Analysis, Trends & Future Outlook"Executive Summary Oral Targeted Oncology Drug Market Market: Growth Trends and Share Breakdown The global oral targeted oncology drug market size was valued at USD 20.73 billion in 2025 and is expected to reach USD 43.47 billion by 2033, at a CAGR of 9.70% during the forecast period In this competitive marketplace, businesses are always in struggle to seek...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Precision Oncology Drug Portfolio Market Size, Industry Development and Forecast Insights"Executive Summary Precision Oncology Drug Portfolio Market Market: Share, Size & Strategic Insights The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period This Precision Oncology Drug Portfolio Market Market research...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Precision Oncology Drug Portfolio market Forecast: Trends, Demand & Revenue Analysis"Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast...0 Комментарии 0 Поделились 656 Просмотры 0 предпросмотр
-
Precision Oncology Drug Portfolio market Forecast: Trends, Demand & Revenue Analysis"Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast...0 Комментарии 0 Поделились 629 Просмотры 0 предпросмотр
-
Acalabrutinib Market Research Highlights Innovation in Modern Oncology SolutionsAcalabrutinib Market Research Highlights Innovation in Modern Oncology Solutions The Acalabrutinib Market research emphasizes the growing role of innovative therapies in reshaping global oncology treatment standards. The healthcare industry is increasingly adopting targeted medicines designed to improve treatment outcomes while reducing unwanted side effects. Acalabrutinib has gained...0 Комментарии 0 Поделились 591 Просмотры 0 предпросмотр
-
Accelerating Momentum: Factors Driving Oncology Device Market GrowthThe continuous Oncology Device Market growth is a testament to the effectiveness of new treatment modalities and the rising awareness about early cancer detection. Major accelerators include the establishment of specialized cancer hospitals and clinics, which require state-of-the-art equipment for comprehensive patient care. This systematic infrastructure development globally is a...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Adult Malignant Glioma Therapeutics Market Opportunities in Personalized Oncology SolutionsThe globalAdult Malignant Glioma Therapeutics Market is witnessing robust growth, driven by rising demand for effective treatment options. According to the report by The Insight Partners, the market size stood at US$ 2.80 Billion in 2024 and is projected to reach US$ 5.39 Billion by 2031, registering a CAGR of 9.8% during the forecast period 2025-2031. Market Overview...0 Комментарии 0 Поделились 536 Просмотры 0 предпросмотр
-
Asia-Pacific PDX Models Market Accelerates with Rising Oncology Research InvestmentsAccording to the latest report published by Data Bridge Market Research, the Asia-Pacific Patient Derived Xenograft (PDX) Models Market CAGR Value To impart a supreme quality to this persuasive Asia-Pacific Patient Derived Xenograft (PDX) Models Market report, unswerving efforts of enthusiastic, dynamic and skilled researchers and analysts have been utilized. Evaluations...0 Комментарии 0 Поделились 250 Просмотры 0 предпросмотр
-
Advancements in Biopharmaceuticals Accelerate the Global EPO Drugs MarketGlobal Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Asia-Pacific Radiotherapy Market Size, Share and Forecast Report to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Radiotherapy Market The Asia-Pacific radiotherapy market size was valued at USD 1.06 billion in 2024 and is expected to reach USD 2.40 billion by 2032, at a CAGR of 11.2% during the forecast period Market definition mentioned in this Asia-Pacific...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. A team involved in preparing this Blood Cancer Market research report has kept certain things into...0 Комментарии 0 Поделились 728 Просмотры 0 предпросмотр
-
Brachytherapy: the internal radiation that's making a comebackInstead of zapping from outside, brachytherapy places radioactive seeds or sources inside the tumour. It's used for prostate, cervical, and breast cancer. The radiation oncology market research study shows that brachytherapy is a solid segment, but it's not the fastest‑growing. Why the resurgence? Because high‑dose rate (HDR) brachytherapy is now done in minutes, not hours, and with...0 Комментарии 0 Поделились 711 Просмотры 0 предпросмотр
-
Breast Cancer Drugs Market Size, Share and Forecast Report to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. An international Breast Cancer Drugs...0 Комментарии 0 Поделились 918 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek